| pubmed-article:19364853 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C0033209 | lld:lifeskim |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C0003374 | lld:lifeskim |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C0042523 | lld:lifeskim |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C0032150 | lld:lifeskim |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C0279023 | lld:lifeskim |
| pubmed-article:19364853 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:19364853 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:19364853 | pubmed:dateCreated | 2009-6-25 | lld:pubmed |
| pubmed-article:19364853 | pubmed:abstractText | We tested the effect of probenecid and verapamil in chemosensitizing Plasmodium falciparum to 14 antimalarials using the multidrug-resistant strain V1S and the drug-sensitive 3D7. Verapamil chemosensitizes V1S to quinine and chloroquine. Interestingly, probenecid profoundly chemosensitizes V1S to piperaquine. Thus, probenecid could be used to increase piperaquine efficacy in vivo. | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19364853 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19364853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19364853 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19364853 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19364853 | pubmed:issn | 1098-6596 | lld:pubmed |
| pubmed-article:19364853 | pubmed:author | pubmed-author:NzilaAlexisA | lld:pubmed |
| pubmed-article:19364853 | pubmed:author | pubmed-author:MassenoVictor... | lld:pubmed |
| pubmed-article:19364853 | pubmed:author | pubmed-author:MuriithiSteve... | lld:pubmed |
| pubmed-article:19364853 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19364853 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:19364853 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19364853 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19364853 | pubmed:pagination | 3131-4 | lld:pubmed |
| pubmed-article:19364853 | pubmed:dateRevised | 2010-9-27 | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:meshHeading | pubmed-meshheading:19364853... | lld:pubmed |
| pubmed-article:19364853 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19364853 | pubmed:articleTitle | In vitro chemosensitization of Plasmodium falciparum to antimalarials by verapamil and probenecid. | lld:pubmed |
| pubmed-article:19364853 | pubmed:affiliation | Kenya Medical Research Institute/Wellcome Trust Collaborative Research Program, Kiilfi, Kenya. | lld:pubmed |
| pubmed-article:19364853 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19364853 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19364853 | lld:chembl |
